The cost of Praluent (alirocumab) without insurance can vary significantly based on factors such as dosage, quantity, and the pharmacy where it is purchased. While specific prices are not readily available without an insurance plan, Praluent is a high-cost specialty medication.
What helps lower the cost of Praluent?
For individuals without insurance, or those with high deductibles or co-pays, exploring savings options is crucial. The manufacturer of Praluent, Sanofi, offers a savings program that can help eligible patients reduce their out-of-pocket costs. This program typically provides a co-pay card that can significantly lower the prescription price. Eligibility for these programs often depends on insurance status and income.
Are there other ways to save on Praluent?
Patients may also find cost savings through various patient assistance programs offered by pharmaceutical companies or non-profit organizations. These programs are designed to make expensive medications more accessible to those who cannot afford them. Additionally, comparing prices at different pharmacies, including online and local options, can sometimes yield lower costs.
What is Praluent used for?
Praluent is a prescription medication used to lower low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol. It is typically prescribed for adults with certain types of high cholesterol, including those with inherited high cholesterol (heterozygous familial hypercholesterolemia) or those who have had a heart attack, stroke, or have peripheral artery disease, and have not been able to reach their LDL cholesterol goals with other cholesterol-lowering treatments [1].
How does Praluent work?
Praluent is a PCSK9 inhibitor. It works by blocking the PCSK9 protein in the body. This protein normally attaches to LDL receptors on liver cells and causes them to be broken down. By blocking PCSK9, Praluent allows more LDL receptors to remain on the liver cell surface, which then removes more LDL cholesterol from the blood [1].
When does Praluent's patent expire?
Drug patent expiry dates are crucial for understanding when generic alternatives might become available, potentially lowering costs. Information on specific patent expiry dates for Praluent can be found through specialized databases like DrugPatentWatch.com [2]. Generally, the period of market exclusivity for branded drugs can be extensive, involving both patent protection and regulatory exclusivities.
Who are Praluent's competitors?
Praluent competes in the PCSK9 inhibitor class with other medications such as Repatha (evolocumab), also manufactured by Amgen. Both drugs function similarly by targeting the PCSK9 protein to lower LDL cholesterol [1]. Other cholesterol-lowering medications, including statins, fibrates, and ezetimibe, represent broader competition in the management of high cholesterol.